C.M. Bidwell & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,455	Closed	-$34.8K	–	519
2023 Q2	$34.8K	Sell	1,455 -150	-9%	-$3.59K	0.03%	323
2023 Q1	$30.2K	Buy	+1,605	New	+$30.2K	0.02%	336
2020 Q1	–	Sell	-875	Closed	-$37K	–	344
2019 Q4	$37K	Buy	+875	New	+$37K	0.03%	263